Intravesical bacillus Calmette-Guérin effects in voided urine cytology

Diagnostic Cytopathology

Volumn 37, Issue 6, 2009, Pages 425-426

  Martínez Girón, Rafael ^a,b  

^a Instituto de P Blancas Asturias   (Spain)

^b Marqués de San Esteban 22 28B ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

ARTICLE; BLADDER CARCINOMA; CELL INCLUSION; CYTOLOGY; EPITHELIOID CELL; HISTIOCYTE; HUMAN; PRIORITY JOURNAL; URINALYSIS; URODYNAMICS; BLADDER; MICROBIOLOGY; MYCOBACTERIUM BOVIS; PATHOLOGY; PHYSIOLOGY; URINE;

HUMANS; MYCOBACTERIUM BOVIS; URINARY BLADDER; URINE;

EID: 66649110080     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.20959     Document Type: Article

References (4)

1. Brassell SA, Kamat AM. Contemporary intravesical treatment options for urothelial carcinoma of the bladder. J Natl Compr Canc Netw 2006;4:1027-1036. (Pubitemid 44845491)
2. Takashi M, Schenck U, Koshikawa T, Nakashima N, Ohshima S. Cytological changes induced by intravesical bacillus Calmette-Guérin therapy for superficial bladder cancer. Urol Int 2000;64:74-81. (Pubitemid 30255577)
3. Betz SA, See WA, Cohen MB. Granulomatous inflammation in bladder wash specimens after intravesical bacillus Calmette-Guerin therapy for transitional cell carcinoma of the bladder. Am J Clin Pathol 1993;99:244-248. (Pubitemid 23102717)
4. Bhan R, Pisharodi LR, Gudlaugsson E, Bedrossian C. Cytological, histological, and clinical correlations in intravesical Bacillus Calmette-Guerin immunotherapy. Ann Diagn Pathol 1998;2:55-60. (Pubitemid 128654487)